Magnesium status and ageing: An update

Magnesium Research

Volumn 11, Issue 1, 1998, Pages 25-42

  Durlach, Jean ^a,f   Bac, Pierre ^b   Durlach, Vincent ^c   Rayssiguier, Yves ^d   Bara, Michel ^e   Guiet Bara, Andrée ^e  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Clinique Médicale U62   (France)

^d CEMAGREF   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f Magnesium Research   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM;

AGE; AGING; DIET; HUMAN; MAGNESIUM DEFICIENCY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR;

AGE FACTORS; AGING; DIET; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; RISK FACTORS;

EID: 0032018286     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (227)

1. Durlach, J., Durlach, V., Bac, P., Rayssiguier, Y., Bara, M. and Guiet-Bara, A. (1993): Magnesium and ageing. II. Clinical data: aetiological mechanisms and pathophysiological consequences of magnesium deficit in the elderly patients. Magnes. Res. 6, 379-394.
2. Durlach, J. and Bac, P. (1997): Mechanisms of action on the nervous system in magnesium deficiency and dementia. In: Mineral and Metal Neurotoxicology, eds M. Yasui, M.J. Strong, K. Ota and M.A. Verity , Ch.20, 201-203. Boca-Raton: CRC Press.
3. Delbet, P. (1963): Rôle du magnésium dans la sénilité. In: Politique préventive du cancer, pp. 101-135. Montreuil: La Vie Claire.
4. An. Symposium on Nutrition and Ageing (1992): Nutr. Rev. 50, 347-489.
5. Durlach, J. (1988): Magnesium in clinical practice, p.360, London: John Libbey.
6. Rayssiguier, Y., Durlach, J., Guiet-Bara, A and Bara, M. (1990): Ageing and magnesium status. In: Metal ions in biology and medicine, eds Ph. Collery, L.A. Poirier, M. Manfait and J.C. Etienne, pp. 62-66. Paris: John Libbey Eurotext.
7. Costello, R.B. and Moser-Veillon P.B. (1992): A review of magnesium intake in the elderly. A cause for concern? Magnes. Res. 5, 61-68.
8. Löwik, M.R.H., Van Dokkum, W., Kistemaker, C., Schaafsma, G. and Ockhuizen, T. (1993): Body composition, health status and urinary magnesium excretion among elderly people (Dutch Nutrition Surveillance System). Magnes. Res. 6, 223-232
9. Singh, R.B., Niaz, M.A., Ghosh, S. and Rastogi, V. (1996): Epidemiological study of magnesium status and risk of coronary artery disease in elderly rural and urban populations of North India. Magnes. Res. 9, 165-172.
10. Singh, R.B., Rastogi, V., Singh, R. Niaz, M.A., Srivastav, S., Aslam, M and Singh, N.K. (1996): Magnesium and antioxidant vitamin status and risk of complications of ageing in an elderly urban population. Magnes. Res. 9, 299-306.
11. Rayssiguier, Y., Durlach, J., Gueux, E., Rock, E. and Mazur, A (1993): Magnesium and ageing. I. Experimental data: importance of oxidative damage. Magnes. Res. 6, 369-378.
12. Classen, U.G., Seitz, G., Grimm, P. and Classen, H.G. (1994): Influence of high and low dietary magnesium levels on functional, chemical and morphological parameters of 'Old' rats. Magnes. Res. 7, 223-243.
13. Heroux, O., Peter, D. and Heggtveit, A. (1977): Long term of suboptimal dietary Mg on Mg and Ca contents of organs on cold tolerance and on life-span and its pathological consequences in rats. J. Nutr. 107, 1640-1652.
14. Durlach, J. (1997): Neurodegenerative diseases and magnesium status. In: Magnesium: Current Status and New Developments, eds T. Théophanides and J. Anatassopoulou, pp.7-16. Dordrecht-Boston-London: Kluwer Academic Publishers.
15. Durlach, J., Bac, P., Durlach, V., Durlach, A., Bara, M. and Guiet-Bara, A. (1997): Are age-related neurodegenerative diseases linked with various types of magnesium depletion? Magnes. Res. 10, 339-353.
16. Durlach, J. (1989): Recommended dietary amounts of Mg: Mg RDA. Magnes. Res. 2, 195-203.
17. Durlach, J. and Mareschi, J.P. (1991): Recommended dietary amounts for magnesium. II. Updated European consensus and future prospects. In: B. Lasserre, J. Durlach eds pp. 39-49. London: John Libbey.
18. Durlach, J., Durlach, V., Bara, M. and Guiet-Bara, A (1992): Pour une réévaluation des apports quotidiens recommandés en magnésium. Med. et Nutr. 28, 9-15.
19. Durlach, J. (1992): Magnesium. In: Apports nutritionnels conseillés pour la population française, eds H. Dupin. J. Abraham, I. Giachetti, pp.37-38 134-135. Paris: Tec. Doc. Lavoisier.
20. Seelig, M.S. (1981): Magnesium requirements in human nutrition. Magnes.-Bull. 3/1a, 26-54.
21. Galan, P., Preziosi, P., Durlach, V., Valeik, P., Ribas, L., Bouzid, D., Favier, A. and Hercberg, S. (1997): Dietary magnesium intake in a French adult population. Magnes. Res. 10, 321-328.
22. Seelig, M.S. (1983): Possible roles of magnesium in disorders of the aged: intervention in the ageing process In: Quantifation, epidemiology, clinical research. eds W. Regelson and F.M. Sinek, pp.279-305. New York: A.R. Liss.
23. Hegsted, D.M. (1989): Recommended dietary intakes of elderly subjects. Am. J. Clin. Nutr. 50, 1190-1194.
24. Schneider, E.L., Vining, E.M., Hadley, E.C. and Farnham, S.A. (1986): Recommended dietary allowances and the health of the elderly. New Engl. J. Med. 314, 157-160.
25. Pennington, J.A.T. and Young, B.E. (1991): Total diet study nutritional elements 1982-1989. J. Am. Diet. Assoc. 91, 179-183.
26. Abdulla, M. and Reis, F. (1991): How adequate is the dietary intake of magnesium from a global point of view? Magnes. Res. 4, 248-249.
27. Vir, S.C. and Love, A.H.G. (1979): Nutritional status of institutionalized and non-institutionalized aged in Belfast. Am. J. Clin. Nutr. 32, 1934-1937.
28. Baghurst, K.I. and Record, S.J. (1987) : The vitamin and mineral intake of a free living young elderly Australian population in relation to total diet and supplementation practices. Human Nutr. Appl. Nutr. 41A, 327-337.
29. Horvath, C.C. (1989): Dietary survey of a large random sample of elderly people energy and nutrient intakes. Nutr. Res. 9. 479-482.
30. Kant, A.K., Moser-Veillon, P.B. and Reynolds; R.D. (1989): Dietary intakes and plasma concentrations of Zn, Cu, Fe, Mg and Se of young, middle aged and older men. Nutr. Res. 9, 717-724.
31. Nieman, D.C., Underwood, B.C., Sherman, J.M., Arabatsis. K., Barbosa, J.C., Johnson, M. and Shulte, T.D. (1989): Dietary status of seventh day adventist vegetarian and non vegetarian elderly women. J. Am. Diet. Assoc. 89, 1763-1769.
32. North, B.B., Burkholder, V.R. and Anderst, C.F. (1989): Folic acid and magnesium status of a group of very old women (abst). J. Am. Diet. Assoc. 89,A.94.
33. Melchionda, N., Enzi, G., Gatto, A.M.R., Parenti, M. and Babini, A.C. (1989): Magnesium intake in the elderly. Italian multicentre study. Magnes. Res. 2, 140.
34. Anderson-Hassam, E. and Hoint-Pradier, F. (1990): Les comportements et consommations alimentaires des personnes âgées. Med. et Nutr. 26, 91-97.
35. Baghurst, K.I., Dreosti, I.E., Syrette, J.A., Record, S.J., Baghurst, P.A. and Buckley, R.A. (1991): Zinc and magnesium status of Australian adults. Nutr. Res. 11, 23-32.
36. Lamisse, F., Decaux, A., Delarue, J., Couet, C., Constant, T., Rivole, M., Moreau, L., Barbieux, J.P., Dardaine, V., Mghabar, G. and Bouyou, E. (1991: Enquête alimentaire par semainier pour l'étude d'une population âgée vivant à domicile. Med. et Nutr., 27, 63-70.
37. Abdulla, M., Jagerstad, M. and Svenson, S. (1976): Kostundersokmng med dubbel-portiontcknik bland pensionärer i Dalby: Ca, Mg, Zn. In : Nordisk Gerontologi Förhandlingar fran Andra Nordiska Kongressen i Gerontologi i Göteborg 4-7 may 1975. eds B. Steen and A. Svanbord, pp. 248-250. Astra. Södertalge.
38. Abdulla, M. (1976): Dietary intake of electrolytes and trace elements in the elderly. Nutr. Metab. 20, 187.
39. Greeger, J.L. (1977): Dietary intake and nutritional status in regard to Zn of institutionalized aged. J. Geront. 32, 549-553.
40. Moreiras-Varela, O., Ortega, R.M., Ruiz-Roso, B. and Varela, G. (1986): Nutritional status of an institutionalized elderly group in Segovia (Spain). Internat. J. Vit. Nutr. Res. 56, 109-117.
41. Classen, H.G., Schimatschek, H.F., Disch, G. and Stierle, R. (1989): Magnesium deficiency in institutionalized elderly persons. Magnes. Res. 2, 297-298.
42. Thomas, A.J., Bunker, V.W., Sodha, N. and Clayton, B.E. (1989): Ca, Mg and P status of elderly in patients: dietary intake, metabolic balance studies and biochemical status. Br. J. Nutr. 62, 211-219.
43. Touitou, Y., Touitou, C., Bogdan, A. and Godard, J.P. (1989): Physiopathological changes of magnesium metabolism with ageing. In: Magnesium in health and disease, eds Y. Itokawa and J. Durlach, pp. 103-110. London-Paris: John Libbey.
44. Durlach, J. (1988): Magnesium deficits secondary to stress. In: Magnesium in clinical practice. pp. 140-147. London-Paris: John Libbey
45. Alfray, A.C., Miller, N.L. and Butkus, D. (1974): Evaluation of body Mg stores. J. Lab. Clin. Invest. 84, 153-162.
46. Mountokalakis, T.D. (1987): Effect of ageing, chronic disease and multiple supplements on magnesium requirements. Magnesium. 6, 5-11.
47. Simeckova, A., Zamrazil, V. and Cerovska, J. (1996): Morning magnesiuria: relation to age and sex. Magnes. Res. 9, 41-45.
48. Parnetti, L., Mecocci, P., Neri, C., Palazetti, D., Fiaconni, M., Santucci, A. Santucci, C., Ballatori, E., Reboldi, G.P., Caputo, N., Signorini, E. and Senin, U. (1990): Neuroendocrine markers in ageing brain: clinical and neurobiological significance of dexamethasone suppression test. Aging, 2, 173-179.
49. Selye, H. and Tuchweber, B. (1976): Stress in relation to ageing and disease. In: Hypothalamus, pituitary and disease, eds A. Everitt and J. Burgess, pp. 567-573. Springfield: C.C. Thomas.
50. Sapolsky, R.M., Krey, L.C. and McEwen, B.S. (1986) : The neuroendocrinology of stress and ageing: the glucocorticoid cascade hypothesis. Endocrine Rev. 7, 284-301.
51. Sapolski, R. M. (1986): Glucocorticoid toxicity in the hippocampus: temporal aspects of synergy with kainic acid. Neuroendocrinology, 43, 440-444.
52. Landfield, P.W. and Eldridge, J.C. (1991): The glucocorticoid hypothesis of brain ageing and neurodegeneration: recent modifications. Acta endocrinol. 125 (Supp.1), 54-64.
53. Kerr, D.W., Campbell, L.W., Applegate, M.D., Brodish, A. and Landfield, P.W. (1991): Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal ageing. J. Neuroscience, 11, 1316-1324.
54. Landfield, P.W., Thibault, O., Mazzanti, M.L., Porter, N.M. and Kerr, D.S. (1992): Mechanisms of neuronal death on brain ageing and Alzheimer's disease: role of endocrine mediated calcium dyshomeostasis. J. Neurobiol. 23, 1247-1260.
55. de Kloet, E.R., Sutanto, W., Rots, N., van Haarst, A., van den Berg, D., Oitzu, M., van Eekelen, A. and Voorhuis, D. (1991): Plasticity and function of brain corticosteroid receptors during ageing. Acta Endocrinol 125, 65-72.
56. Rothuisen, J., Reuc, M.H.M., Rijnberk, A., Mol, J.A. and de Kloet , E.R. (1991): Ageing and the hypotalamus-pituitary-adrenocortical axis with special reference to the dog. Acta EndocrinoL 125, 73-76.
57. van Eekelen, J.A.M., Rots, N.Y., Sutanto, W. and de Kloet, E.R. (1991): The effect of ageing on stress responsiveness and central corticosteroid receptors in the Brown Norway rat. Neurobiology of Aging. 13. 159-170.
58. McEwen, B.S., Gould, E.A. and Sakai, R.R. (1992): The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br. J. Psychiatry, 160/Supp. 15, 18-23.
59. Raadsheer, F.C., Tilders, F.J.H. and Swaab, D.F. (1994): Similar age related increase of vasopressin colocalization in paraventricular CRH neurons in controls and Alzheimer's patients. J. Neuroendocrinol. 6, 131-133.
60. Raadsheer, F.C., Oorschot, D.E., Vermer, R.W.H., Tilders, F.J.H. and Swaab, D.F. (1994): Age related increase in the total number of corticotrophin-releasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's disease: comparison of the dissector with an unfolding method. J. Comp. Neurol. 339, 447-457.
61. Swaab, D.F., Raadsheer, F.C., Endert, E., Hoffman, M.A., Kamphorst, W. and Ravid, R. (1994): Increased cortisol levels in ageing and Alzheimer's disease in post mortem cerebrospinal fluid. J. Nuroendocrinol. 6, 681-687.
62. Nasman, B., Olsson, T., Sfkl, J.R. et al. (1994): Abnormalities in adrenal androgens, but not of glucocorticoids in early Alzheimer's disease. Psychoneuroendocrinology, 20, 83-94 (cited in 66).
63. Raadsheer, F.C., Van Heerikhuise, J.J., Lucassen, P. J., Hoogendijk, W.J., Tilders, F.J.H., and Swaab, D.F. (1995): CRH mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease or depression. Am. J. Psych. 152, 1372-1376.
64. Sapolsky, R.M. (1996): Stress, glucocorticoids and damage to the nervous system: the current state of confusion. Stress, 1, 1-19.
65. Sapolsky, R.M. (1996): Why stress is bad for your brain? Science, 273, 749-750.
66. Angelucci, L. (1997): Glucocorticoid hormone, ageing brain and dementia. Funct. Neurol., 12, 167-173.
67. Lehmann, A., Hagberg, H, Nystrom, B., Sandberg, M. and Hamberger A. (1985): In vivo regulation of extracellular taurine and other neuroactive aminoacids in the rabbit hippocampus. In: Taurine biological actions and clinical perspectives, eds S.S. Oja, A. Liisa, K. Pirjo. and K.P. Matti, pp. 289-311. New York: A. Liss.
68. Varga, V., Janaky, R., Holopainen, I. and Kontro, P. (1990): Effect of glutamyl-taurine on calcium influx in cultured cerebellar granule cells. In: Taurine: functional neurochemistry, physiology and cardiology, eds W.S. Shain, H. Pasantes-Morales and R. Martin Del Rio, pp. 141-145. New York: Wiley-Liss.
69. Schousboe, A. (1992): Role of taurine in neural cell volume regulation. Can. J. Physiol. Pharmacol. 70, S 356 - S 361.
70. Huxtable, R.J. (1992): Physiological actions of taurine. Phys. Rev. 72, 101-163.
71. Porras, A. and Mora, F. (1993): Dopamine receptors antagonist blocks the release of glycine, GABA and taurine produced by amphetamine. Brain Res. Bull. 31, 305-310.
72. Saransaari, P and Oja, S.S. (1994): Taurine release from mouse hippocampal slices: effect of glutamatergic substances and hypoxia. In: Taurine in health and disease, eds R. Huxtable and D.V. Michalk, pp.279-287. New York: Plenum Press.
73. Wu, J -Y., Chin-Tarng, L., Johansen, F.F. and Liu, J.W. (1994): Taurine neurons in rat hippocampal formation are relatively inert to cerebral ischemia. In: Taurine in health and disease, eds R. Huxtable and D.V. Michalk, pp.289-298. New York: Plenum Press.
74. Sgaragli, G., Frosini, M., Palmi, M., Bianchi, L. and Della Corte, L. (1994): Ca and taurine interaction in mammalian brain metabolism. In: Taurine in health and disease, eds R. Huxtable and D.V. Michalk, pp. 299-308. New York: Plenum Press.
75. Trenkner, E., Liu, D., Harris, C. and Sturman, J. (1994): Regulation of proteinkinase C activity by taurine and b alamine during excitotoxicity in cat and mouse cerebellar cultures. In: Taurine in health and disease, eds R. Huxtable and D.V. Michalk, pp.309-316. New York: Plenum Press.
76. Pasantes-Morales, H., Chacon, E., Sanchez-Olea, R. and Moran, J. (1994): Volume regulation in cultured neurons: pivotal role of taurine. In: Taurine in health and disease, eds R. Huxtable and D.V. Michalk, pp.317-323. New York: Plenum Press.
77. Bliss, T.V.P. and Lynch, M.A. (1988): Long term potentiation of synaptic transmission in the hippocampus: properties and mechanisms. In: Long-term potentiation: from biophysics to behaviour, eds P.W. Landfield and S.A. Deadwiller, pp.3-72. New York: A. Liss.
78. Nicoletti, F., Casabona, G., Genazzani, A.A., Copani, A., Aleppo, G., Canonico, P.L. and Scapagnini, V. (1992): Excitatory amino acids and neuronal plasticity: modulation of AMPA receptors as a novel substrate for the action of nootropic drugs. Functional Neurology, 7, 413-422.
79. Vink, R. and McIntosh, T.K. (1990): Pharmacological and physiological effects of Mg on experimental traumatic brain injury. Magnes. Res., 3, 163-169.
80. Lui, A.H. and Horowitz, J.M. (1992): Modulation of paired-pulse facilitation by temperature, Ca, Mg and picrotoxin in the hamster hippocampus. FASEB J. (abs. 1517), A 1193.
81. 2+ ratios on frequency potentiation in hippocampal slices of young and aged rats. J. Neurophysiol. 56, 797-798.
82. 2+ improves hippocampal frequency potentiation and reversal learning in aged and young rats. Brain Res. 322, 167-171.
83. Durlach, J., Poenaru, S., Rouhani, S., Bara, M. and Guiet-Bara, A. (1987): The control of central neural hyperexcitability in magnesium deficiency. In: Nutrients and Brain Function, ed. W.B. Essman, pp. 48-71. Basel: S. Karger.
84. Bac, P., Herrenknecht, C., Binet, P. and Durlach, J. (1993): Audiogenic seizures in magnesium deficient mice: effects of magnesium pyrrolidone-2-carboxylate, magnesium acetyltaurinate, magnesium chloride and vitamin B6. Magnes. Res. 6, 11-19.
85. Bac, P., Herrenknecht, C., Binet, P. and Durlach, J. (1993): Effects of various magnesium salts on the actions of systemic kainic acid in magnesium deficient rats: a new model of accelerated hippocampal ageing-like injury? (abs). Magnes. Res. 6, 300-301.
86. Bac, P., Herrenknecht, C., Pages, N., Dupont, C and Durlach, J. (1997): Reversible model of magnesium depletion induced by systemic kainic acid injection in magnesium deficient rats. I. Comparative study of various magnesium salts. Magnes. Res. 6, 281-292.
87. Pavlov, E.P., Harman, S.M., Chrousos, G.P., Loriaux, D.L. and Blackman, M.R. (1986): Responses of plasma adrenocorticotrophin, cortisol and dihydroepiandrosterone to ovine CRH in healthy ageing men. J. Clin. Endocrinol. Metab. 62, 767-772.
88. Olsson, T., Vittanen, M., Hagg, E., Asplund, K., Grankvist, K., Erikson, S. and Gustafson, Y. (1989): Hormones in "young" and "old" elderly: pituitary thyroid and pituitary-adrenal axes. Gerontology, 35, 144-152.
89. Touitou, Y;. Sulon, J., Bogdan, A., Reinberg, A., Sodoyez, J.C. and Demay-Ponsart, E. (1983): Adrenocortical hormones, ageing and mental condition: seasonal and circadian rhythms of plasma 18 OH, 11 deoxy corticosterone, total and free cortisol and urinary corticosteroids. J. Endocrinol. 96, 53-64.
90. Sherman, B., Wysham, C. and Pfohl, B. (1985): Age related changes in the circadian rhythm of plasma cortisol in man. J. Clin. Endocrinol. Metabol. 61, 439-443.
91. Sharma, M., Palacios-Bois, J., Schwartz, G, Iskandar, H., Thakur, M., Quirion, R. and Nair, N.P. (1989): Circadian rhythms of melatonin and cortisol in ageing. Biol. Psychiatry, 25, 305-319.
92. Goldenberg, F. (1991): Le sommeil du sujet âgé normal. Neurophysiol. Clin. 21, 267-279.
93. Cugini, P., Lucia, P., Di-Palma, L., Ré, M., Canona, R., Gasbaronne, L. and Clanetti, A. (1992): The circadian rhythm of atrial natriuretic peptide, vasoactive intestinal peptide, beta-endorphin and cortisol in healthy young and elderly subjects. Clin. Auton. Res. 2, 113-118.
94. Velloso Da Costa, A. (1996): Magnesium, antioxidants and longevity. In: Current Research in Magnesium, eds M.J. Halpern and J. Durlach, pp.265-268. London: John Libbey.
95. Georgotas, A., McCue, R.E., Kim, O.M., Hapworth, W.E., Reisberg, B., Stoll, P.M., Sinaiko, E., Fanelli, C. and Stokes, P.E. (1986): Dexamethasone suppression in dementia, depression and normal ageing. Am. J. Psychiatry, 143, 452-456.
96. Stuck, A.E., Frey, B.M. and Frey F.J. (1988): Kinetics of prednisolone and endogenous cortisol suppression in the elderly. Clin. Pharmacol. Ther. 43, 354-362.
97. Armanini, D., Karboviak, I., Scali, M., Orlandini, E., Zampollo, V. and Vitadello, G. (1992): Corticosteroid receptors and lymphocyte subsets in mononuclear leucocytes in ageing. Am. J. Physiol., 262 (4Pt1), E464-E466.
98. Heuser, I.J.E., Wark, H.J., Keul, J. and Holsboer, F. (1991): Hypothalamic-pituitary-adrenal axis function in elderly endurance athletes. J. Clin. Endocrinol. Metabol. 73, 485-488.
99. Olefski, J. (1975): Effect of dexamethasone on insulin binding, glucose transport and glucose oxidation of isolated rat adipocytes. J. Clin. Invest. 56, 1499-1508.
100. Rizza, R.A., Mandarino, L.J. and Gerich, J.E. (1982): Cortisol-induced resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor of insulin action. J. Clin. Exp. Med. 54, 131-138.
101. Amatruda, J.M., Danahy, S.A. and Chang, C.L. (1983): The effects of glucocorticoids on insulin-stimulated lipogenesis in primary cultures of rat hepatocytes. Biochem. J. 212, 135-141.
102. Plested, C.P., Taylor, E., Brindley, D.N. and Vernon, R.G. (1987): Interaction of insulin and dexamethasone in the control of pyruvate kinase activity and glucose metabolism in sheep adipose tissue. Biochem. J. 247, 459-465.
103. Bathena, S. (1987): Insulin receptor. In: Peptide hormone receptors. pp.180-285. Berlin-New York: W. de Gruyter.
104. Brindley, D.N. and Rolland, Y. (1989): Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin. Sc. 77, 453-461.
105. Stojanovska, L., Rosella, G. and Proietto, J. (1990): Evolution of dexamethasone induced insulin-resistance. Am. J. Physiol. 258, E748-E756.
106. Guillaume-Gentil, C., Assimacopoulos-Jeannet and Jeanrenaud, B. (1993): Involvment of NEFA oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia , 36, 899-906.
107. de Fronzo, R.A. (1979): Glucose intolerance and ageing. Evidence for tissue insensitivity to insulin. Diabetes, 28, 1095-1101.
108. Fink, R.J., Kolterman, O.G., Griffin, J. and Olefsky, J.M. (1993): The mechanisms of insulin-resistance in ageing. J. Clin. Invest. 73, 1523-1535.
109. Rowe, J.W., Minaker, K.L., Pallota, J.A. and Flier, J.S. (1983): Characteristics of insulin resistance in ageing. J. Clin. Invest. 71, 1581-1587).
110. de Fronzo, R.A. and Ferrannini, E. (1991): Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-174.
111. Durlach, J. and Rayssiguier, Y. (1983): Données nouvelles sur les relations entre magnésium et hydrates de carbone. I. Données physiologiques. Magnesium, 2, 174-191.
112. Durlach, J. (1988): Magnesium deficit in diabetes mellitus. In: Magnesium in clinical practice, pp 156-169. London, Paris: John Libbey.
113. Barbagallo, M., Gupta, R.K. and Resnick, L.M. (1993): Cellular ionic effects of insulin in normal human erythrocytes: a nuclear magnetic resonance study. Diabetologia, 36, 146-149.
114. Grulet, H., Durlach, V., Hecart, A.C., Gross, A. and Leutenegger, M. (1993): Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index. Diabetes Res. Clin. Pract 20, 201-207.
115. Girerd, X., Laurant, S. and Safar, M. (1986): Récepteurs adrénergiques et hypertension artérielle. Gaz. Med. 93, 33-39.
116. Raskind, M.A., Peskind, E.R., Veith, R.C., Beard, J.C., Gumbrecht, G. and Halter, J.B. (1988); Increased plasma and cerebrospinal fluid norepinephrine in older men: differential suppression by clonidine J. Clin. Endocrinol. Metab. 66, 438-443.
117. Durlach, J. (1988): Regulation of magnesium metabolism. In: Magnesium in clinical practice, pp 20-39. London, Paris: John Libbey.
118. Durlach, J. (1988): Secondary magnesium deficits. In: Magnesium in clinical practice, pp 114-194. London, Paris: John Libbey.
119. Paolisso, G., Marrazzo, G., de Riu, S., Sgambato, S., Varrichio, M., d'Onofrio, F. and Lefebvre, P. (1992): Effects of mild-to-moderate hyperglycaemia per se on glucose production and uptake in the elderly. Eur. J. Med. 1, 6-12.
120. de Leeuw, I., van Acker, K. and Rillaeets, E. (1991): Magnesium and diabetes mellitus (abst). Magnes. Res. 4, 229.
121. de Leeuw, I., Vansant, G. and Van Gaal, L. (1992): Magnesium and obesity: influence of gender, glucose tolerance and body fat distribution on circulating magnesium levels. Magnes. Res. 5, 183-187.
122. Paolisso, G., Sgambato, S., Gambardella, A., Pizza, G., Tesauro, P., Varrichio, M. and d'Onofrio F. (1992): Daily magnesium supplements improve glucose handling in elderly subjects. Am. J. Clin. Nutr. 55, 1161-1167.
123. Durlach, J. and Rayssiguier, Y. (1983): Données nouvelles sur les relations entre magnésium et hydrates de carbone II. Données cliniques. Magnesium, 2, 192-224.
124. Hua, H., Gonzales, J. and Rude, R.K. (1995): Magnesium transport induced ex vivo by a pharmacological dose of insulin is impaired in NIDDM. Magnes. Res. 8, 359-366.
125. Durlach, J. (1988): Secondary magnesium deficits: chronic alcoholism. In: Magnesium in clinical practice, pp 120-133. London, Paris: John Libbey.
126. Queneau, P., Chabot, J.M., Rajaona, H., Boissier, C. and Grandmottet, P. (1992): Iatrogénie observée en milieu hospitalier I. A propos de 109 cas colligés à partir d'une étudde transversale de l'APNET. Bull Acad. Nationale Med. 176, 511-529.
127. Abdulla, M., Behbehani, A. and Dashti, H. (1989): Marginal deficiency of magnesium and suggested treatment. In: Magnesium in health and disease. eds Y. Itokawa and J. Durlach, pp. 111-117. London, Paris: John Libbey.
128. Ising, H., Nawroth, H. and Gunther, T. (1981): Accelerated ageing of rats by magnesium deficiency and noise stress. Magnes.-Bull. 3, 142-145.
129. Rayssiguier, Y. and Durlach, J. (1981): Déficit magnésique marginal et lésions hépatiques expérimentales du rat. Med. Chir. Dig. 10, 312-316.
130. Rayssiguier, Y., Chevalier, F., Bonnet, M. , Kopp, J. and Durlach, J. (1985): Influence of magnesium deficiency on liver collagen after carbonetrachloride or ethanol administration to rats. J. Nutr. 115, 1656-1662.
131. Durlach, J., Bara, M. and Guiet-Bara, A. (1989): Magnesium in drinking water: its importance in cardiovascular risk. In: Magnesium in health and disease, eds Y. Itokawa and J. Durlach, J., pp. 173-182. London, Paris: John Libbey.
132. Rayssiguier, Y., Mazur, A., Cardot, P. and Gueux, E. (1989): Effect of magnesium on lipid metabolism and cardiovascular diseases. In: Magnesium in health and disease, eds I.Ytokawa, and J. Durlach, pp. 199-208. London, Paris: John Libbey.
133. Fehlinger, R. (1989): Accelerated ageing in magnesium deficient man. Magnes. Res. 2, 67.
134. Mahfouz, M. and Kummerow, F.A. (1989): Effect of magnesium deficiency on delta-6-desaturase activity and fatty acid composition of rat liver microsomes. Lipids, 24, 727-732.
135. Hanada, K., Suzuki, I., Hashimoto, I., Sone, K. and Ishida, K (1989): Aetiologic role of leukotriene B4 and superoxide anion on magnesium deficiency dermatites. Magnes. Res., 2, 19.
136. Durlach, J., Bara, M. and Guiet-Bara, A. (1990): Magnesium and its relationship to oncology. In: Metal ions in biological system. VoL 26 Compendium on magnesium, eds H. Sigel and A. Sigel, pp. 549-578. New York, Basel: M. Dekker Inc.
137. Kubena, K.S. and Durlach J. (1990): Historical review of the effects of marginal intake of magnesium in chronic experimental magnesium deficiency. Magnes. Res. 3, 219-226.
138. Classen, H.G. and Schimatschek. H.F. (1991): Age dependent interactions between magnesium metabolism and the manifestation of stress (abst). Magnes. Res. 4, 237.
139. Poenaru, S., Aymard, P., Durlach, J., Manicom, R., Poenaru, L., Rouhani, S., Rayssiguier, Y., Emmenouilidis, E., Gueux, E., Nkanga, N. and Soulairac, A. (1991): Regional distribution of magnesium in the cerebral tissues in normal and magnesium deficient rat (abst). Magnes. Res. 4, 246.
140. Gunther, T. (1991): Magnesium deficiency, oxygen radicals and ageing. Magnes. Bull. 13, 78-81.
141. Gunther, T., Vormann, J., Hollriegl, V., Disch, G. and Classen, H.G. (1992): Role of lipid peroxidation and vitamin E in magnesium deficiency. Magnes. Bull 14, 57-66.
142. McCoy, H. and Kenney, M.A. (1992): Magnesium and immune function: recent findings. Magnes. Res. 5, 281-293.
143. Rayssiguier, Y., Mbega, J.D., Durlach, V., Gueux, E., Durlach, J., Giry, J., Dalle, M., Mazur, A. and Berthelot, A. (1992): Magnesium and blood pressure. I. Animal studies. Magnes. Res. 5, 139-146.
144. Rayssiguier, Y., Gueux, E., Durlach, V., Durlach, J., Nassir, F. and Mazur, A. (1992): Magnesium and the cardiovascular system: I. New experimental data on magnesium and lipoproteine. In: Molecular biology of atherosclerosis. ed. M.J. Halpern, pp. 505-512. London: John Libbey.
145. 2+ supresses sulfation of glycoconjugates secreted from rabbit trachea in culture. Japan J. PharmacoL 60, 247-252.
146. Caddell, J.L. and Dunn, J.D. (1992): Plasma corticosterone in stressed magnesium deficient weanling rats. Magnes. Trace Elem. 10, 40-46.
147. Freedman. A.M., Mak, I.T., Stafford, R.E., Dickens, B.F., Cassidy, M.M., Muesing, R.A. and Weglicki, W.B. (1992): Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. Am. J. Physiol. 262, C1371-C1375.
148. Weglicki, W.B. and Phillips, T.M. (1992): Pathobiology of magnesium deficiency: a cytokine neurogenic inflammation hypothesis. Am. J. Physiol. 263, R734-R737.
149. Altura, B.M., Altura, B.T., Gebrewold, A., Ising, H. and Gunther, T. (1992): Noise induced hypertension and magnesium in rats: relationship to microcirculation and calcium. J. Appl. Physiol. 72, 194-202.
150. Kummerow, F.A., Wasowicz, E. Smith, T., Yoss, N.J. and Thiel, J. (1993): Plasma lipid physical properties in swine fed margarine or butter in relation to dietary magnesium intake. J. Am. Coll. Nutr. 12, 125-132.
151. Rayssiguier, Y., Gueux, E., Bussiere, L., Durlach, J. and Mazur, A. (1993): Dietary magnesium affects susceptibility of lipoproteine and tissues to peroxidation in rats. J. Am. Coll. Nutr. 12, 133-137.
152. Müller, W., Iffland, R. and Firstling, R. (1993): Relationship between magnesium and elastic fibres. Magnes. Res. 6, 215-222.
153. Zhou, Q., Mahfouz, M.M. and Kummerow, F.A. (1994): Effect of dietary magnesium deficiency with/without cholesterol supplementation on phospholipid content in liver, plasma and erythrocytes of rabbits. Magnes. Res. 7, 23-30.
154. Yamaguchi, Y., Kitagawa, S. Kunimoto, M. and Fujiwara, M (1994): Preventive effects of magnesium on raised serum lipid peroxide levels and aortic cholesterol deposition in mice fed an atherogenic diet. Magnes. Res. 7. 31-37.
155. Mahfouz, M.M., Zhou, Q. and Kummerow, F. A. (1994): Cholesterol oxide in plasma and lipoproteins of magnesium deficient rabbits and effects of their lipoproteine on endothelial barrier function. Magnes. Res. 7, 207-222.
156. Nakamura, M., Abe, S , Goto, Y. and Ghisaki, A. (1995). Sudden sound induced death in magnesium-deficient rats after repetitive episodes of seizures resulting from brain dysfunction. Magnes. Res. 8, 47-53.
157. Bussière, L., Mazur, A., Gueux, E., Nowacki, W. and Rayssiguier, Y. (1995): Triglyceride-rich lipoproteins from magnesium-deficient rats are more susceptible to oxidation by cells and promote proliferation of cultured vascular smooth muscle cells. Magnes. Res. 8, 151-158.
158. Rock, E., Astier, C., Lab, C., Malpuech, C., Nowacki, W. Gueux, E., Mazur, A. and Rayssiguier, Y. (1995): Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes. Res. 8, 237-242.
159. Weglicki, W.B., Dickens, B.F., Wagner, T.L., Chmielinska, J.J. and Phillips, T.M. (1996): Immuno regulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. Magnes. Res. 9, 3-11.
160. 2+ in vascular smooth cells during dietary magnesium deficiency in rat. Magnes. Res . 9, 101-108.
161. Serebruany, V.L., Herzog, W.R., Edenbaum, L.R., Shutov, A.R. and Gurbel, P.A. (1996): Changes in the haemostatic profile during magnesium deficiency in swine. Magnes. Res. 9, 155-163.
162. Ishiguro, S., Matsuyama, T., Sakoda, T., Sakaguchi, H., Miyamoto, A. and Nishio, A. (1997): Ex vivo study of the effects of dietary magnesium deficiency on the formation and release of NO from endothelial cells and the sensitivity to NO of smooth muscle cells of thoracic aortas isolated from rats. Magnes. Res. 10, 11-20.
163. Ishiguro, S., Matsuyama, T., Sakaguchi, H. and Nishio, A. (1997): Ex vivo study of the increased sensitivity to NO of endothelium-denuded thoracic aortas isolated from dietary magnesium-deficient rats. Magnes. Res. 10, 21-31.
164. Agnoli, A., Nappi, G., Sandrini, G. and de Romani, F. (1989): Role of magnesium administration in neuronal hyperexcitability syndrome. In: Magnesium in health and disease, eds Y. Itokawa and J. Durlach, pp. 299-305. London, Paris: John Libbey.
165. Durlach, J. (1992): Chronic fatigue syndrome and chronic primary magnesium deficiency. Magnes. Res. 5, 68.
166. Durlach, J., Bac, P., Durlach, V., Bara, M. and Guiet-Bara, A. (1997): Neurotic, neuromuscular and autonomic nervous form of magnesium imbalance. Magnes. Res. 10, 169-195.
167. Kral, V.A. (1962): Senescent forgetfulness: benign and malignant. Can. J. Med. 86, 257-260.
168. Schwartz, R.S., Jaeger, L.F. and Veith, R.C. (1987): The importance of
169. Enzi, G., Gasparo, M., Biodetti, P.R., Flore, M.D., Semlsa, M. and Zurlo, F. (1986): Subcutaneous and visceral fat distribution according to sex, age and overweight, evaluated by computed tomography. Am. J. Clin. Nutr. 44, 739-746.
170. Vaughan, L., Zurlo, F. and Ravussin, E. (1991): Ageing and energy expenditure. Am. J. Clin. Nutr. 53, 821-825.
171. Carrascosa, J.M., Ruiz, P., Martinez, C., Pulido, J.A., Satrustegui, J. and Andres, A. (1989): Insulin receptor kinase activity in rat adipocytes is decreased during ageing. Bioch. Biophys. Res. Comm. 160, 303-309.
172. Suarez, A., Pulido, N., Casla, A., Casanova, B., Arrieta, F.J., Romero, R. and Rouira, A. (1992): Tyrosme kinase activity in insulin receptors from hypomagnesemic rats (abst. 317). Diabetologia, 35 (supp.1), A82.
173. Lowney, P., Hannon, T.S and Baron, A.M. (1992): Marginal magnesium intake alters hepatic and peripheral insulin sensitivity in the rat. FASEB J. (abst. 4941), A 1790.
174. Stendig-Lindberg, G., Tepper, R. and Leichter, I. (1993): Trabecular bone density in a two years controlled trial of peroral magnesium in osteoporosis. Magnes. Res. 6, 151-159.
175. Tvedt, K.E., Kostad, G., Haugen, O.A. and Halgunset, J. (1987): Subcellular concentrations of Ca, Zn and Mg in benign nodular hyperplasia of the human prostate: X-raymicroanalysis of freezedried cryosections. Cancer Res. 47, 323-328.
176. Durlach, J. (1988): Methods of evaluating magnesium status. In: Magnesium in clinical practice, pp 40-60. London, Paris: John Libbey.
177. Clemens, R.A. and Brown, R.C. (1986): Biochemical methods for assessing the vitamin and nutritional status of the elderly. Food Technol. 40, 71-81.
178. Henrotte, J.G. and Durlach, J. (1971): Magnésium et biométrie humaine. In: 1er Symposium International sur le Déficit Magnésique en Pathologie Humaine. I. Vol. des Rapports, ed. J. Durlach pp.91-110. Vittel: SGEMV.
179. Landahl, S., Graffner, C., Jagenburg, R., Lunbborg, P. and Steen, B. (1980): Prevalence and treatment of hypomagnesemia in the elderly. Studies in a representative 70 year-old population and in geriatric patients. Akt Gerontol. 10, 397-402.
180. Welsh, D.W. and Ash, O. (1984): Adult references interval for 12 chemistry analyses: influence of age and sex. Am. J. Clin. Pathol. 81, 71-76.
181. Leszek, G. and Del Campo, O. (1985): Role of magnesium in the dietotherapy of degenerative diseases. Importance of magnesium supplementation of diets of elderly patients. In: Magnesium deficiency: physiopathology and treatment implications, eds M.J. Halpern and J. Durlach, pp.239-243. Basel-New York: Karger.
182. Sherwood, R.A., Aryanagagam, P., Rocks, B.F. and Mandikar, G.D. (1986): Hypomagnesium in the elderly. Gerontology, 32, 105-109.
183. Gueux, E., Duchene-Marullaz, P. and Rayssiguier, Y. (1988): Plasma erythrocyte magnesium levels in a French population. Magnes.-Bull. 10, 77-80.
184. Yang, X.Y., Hosseini, J.M., Ruddel, M.E. and Elin, R.J. (1990): Blood magnesium parameters do not differ with age. Am. J. Coll. Nutr. 9. 308-313.
185. Martin, B.J. (1990): The magnesium load test: experience in the elderly. Aging, 2, 291-296.
186. Martin, B.J., Black, J. and McLelland, A.S. (1991): Hypomagnesemia in elderly hospital admissions: a study of clinical significance. Quart. J. Med. 78, 177-184.
187. Martin, B.J., Lyon, T.D.B., Walker, W. and Feil, G.S. (1993): Mononuclear blood cell magnesium in older subjects: evaluation of its use in clinical practice. Ann. Clin. Biochem. 30, 23-37.
188. Cohen, L. and Kitzes, R. (1992): Characterization of the magnesium status of elderly people by the magnesium tolerance test. Magnes.-Bull. 14, 133-134.
189. Gullestad, L., Nes, M., Ronneberg, R., Midtvedt, K, Falch, D and Kjekshus, J. (1993): Magnesium status in healthy free-living elderly Norvegiens. J. Am. Coll. Nutr. 13, 45-50.
190. Toral Revuelta, J.R., Hernandez, D.M.. Ruiz, M.M., Segui, G.L., Paralba Vano, J.I. and Ribera Casado, J.M. (1996): Intravenous magnesium load test in elderly patients with protein-energy malnutrition. Magnes. Res. 9, 293-298.
191. Tsunematsu, K., Tanuma, S. and Sakuma, Y. (1987): Lymphocyte magnesium values in Japanese determined by microanalysing methods. Jap. J. Soc. Magnes. Res. 6, 33-43.
192. Moller, P. (1982): Skeletal muscle adaptation to ageing and to respiratory and liver failure. Acta Med. Scand. Supple. 654, 1-40.
193. Martin, B.J., Lyon, T.D.B. and Feil G.S. (1991): Comparison of inorganic elements from autopsy tissue of young and elderly subjects. J. Trace Elem. Electrolytes Health Dis. 5, 203-211).
194. Hesse, A., Classen, A., Knoll, M., Timmermann, F. and Valensieck, W. (1986): Dependance of urine composition on the age and sex of healthy subjects. Clin. Chim. Acta, 160, 79-86.
195. Lowik, M.D., Schrijver, J., Odink, J., van Denberg, H., Wedel, M. and Hermhs, R.J.J. (1990): Nutrition and ageing: nutritional status of "apparently healthy" elderly (Dutch nutrition surveillance system). J. Am. Coll. Nutr. 9, 18-27.
196. Nicolau, Y., Haus, E., Lakatua, D., Bogdan, C., Petrescu, E, Robu, E., Sackett-Lundeen, L. and Swoyer, J. (1985): Chronobiologic observations of Ca and Mg in the elderly. Endocrinologie, 23, 39-53.
197. Nishimuta, M., Ono, K., Kodema, N., Hattori, M., Tominaga, I., Hiraoka, A. and Miura, I. (1989): Age related increase in serum ultrafiltrable Ca and Mg in human. Magnesium Res. 2, 129.
198. Nishimuta, M., Kodama, N. and Ono, K. (1989): Magnesium uresis by risk factors for chronic degenerative diseases. In: Magnesium in health and diseases, eds Y. Itokawa and J. Durlach, pp. 279-284. London, Paris: John Libbey.
199. Hershey, C.O., Hershey, L.A., Wongmongkolrit, T., Varnes, A.W. and Breslau, D. (1985): Trace element content of brain in Alzheimer's disease and ageing. Trace Elem. Med. 2, 40-43.
200. Durlach, J. (1990): Magnesium depletion and pathogenesis of Alzheimer's disease. Magnes. Res. 3, 217-218.
201. Click, J.L. (1991): Proposed mechanisms for alteration of albumin structure and function in Alzheimer's disease. J. Theor. Biol. 148, 283-286.
202. Glick, J.L. (1990): Use of magnesium in the management of dementias. Med. Sci. Res. 18, 831-833.
203. Borella, P., Giardino, A., Neri, M. and AndermaKer, E. (1990): Magnesium and potassium status in elderly subjects with and without dementia of the Alzheimer type. Magnes. Res. 3, 282-289.
204. Mazur, A., Felgines, C., Feillet, C. Boirie, Y., Bellanger, J., Beaufrère, B., Gueux, E., Rock, E. and Rayssiguier, Y. (1997): Parenteral magnesium loading test in the assessment of magnesium status in healthy adult French subjects. Magnes. Res. 10, 59-64.
205. Durlach, J. (1988): Magnesium and therapeutics. In: J. Durlach (Ref.5), 217-246 and Durlach, J., Durlach, V., Bac. P., Bara, M. and Guiet-Bara, A. (1994): Magnesium and Therapeutics. Magnes. Res. 7, 313-328.
206. Durlach, J. (1988): Magnesium and therapeutics. In: J. Durlach (Ref.5), 217-246 and Durlach, J., Durlach, V., Bac. P., Bara, M. and Guiet-Bara, A. (1994): Magnesium and Therapeutics. Magnes. Res. 7, 313-328.
207. Bara, M., Guiet-Bara, A. and Durlach J. (1988): Modification of human amniotic membrane stability after addition of magnesium salt. Magnes. Res. 1, 23-28.
208. Bara, M., Guiet-Bara, A. and Durlach, J. (1988): Analysis of magnesium membraneous effects: binding and screening. Magnes. Res. 1, 29-34.
209. Schmidbaur, H., Classen, H.G. and Helbig, J. (1990): Asparagin-und glutamin-saure als Liganden für Alkali- und Erdalkalimetalle: Strukturchemische Beiträge zum Fragencomplex der Magnesiumtherapie. Angew. Chem. 102, 1122-1136.
210. Durlach, J., Durlach, V., Bara, M. and Guiet-Bara, A. (1992): A new method of in vitro pre-screening evaluation of several magnesium salts. Meth. and Find. Exptl. Clin. Pharmacol. 14, 305-310.
211. Singh, R.B. (1990): Effect of dietary magnesium supplementation in the prevention of coronary heart disease and sudden cardiac death. Magnes. Trace Elem. 9, 143-151.
212. Durlach. J. (1992): Almonds, monounsatured fats magnesium and hypolipidemic diets. Magnes. Res. 5, 315.
213. Hese, A., Weber, A. and Miersch, W.D. (1988): Magnesium-Substitution durch Minerali-vasser. Therapie-Woche, 38, 2510-2513.
214. Freedman, A.M., Cassidy, M.M. and Weglicki, W.B. (1991): Captopril protects against myocardial injury induced by magnesium deficiency. Hypertension, 18, 142-147.
215. Jaffard, R., Mocaer, E., Lebrun, C. and Beracoche, A. (1991): Effets de la tianeptine sur l'apprentissage et la mémoire chez la souris. Amélioration de certains déficits induits par l'alcoolisation chronique et le vieillissement cérébral. Presse Med. 20, 1812-1816.
216. Delbende, C., Delarue C., Lefebvre, H., Tranchand-Bunel, D., Sfafarczyk, A., Mocaer, E., Kamoun, A., Segou, S. and Vaudry, H. (1992): Glucocorticoids, transmitters and stress. Br. J. Psychiatry, 160, (Suppl. 15), 24-34.
217. Croughs, R.M.J., Rijnbert, A. and Koppeschaar, H.P.F. (1990): Heterogeneity in Cushing disease. Neth. J. Med. 36, 217-220.
218. Pasturel, J. (1984): Le magnésium en gériatrie. Gaz. Méd. 91, 1-3.
219. Merchan. R., Ribello, A. and Franco-Martinez, J. (1986): Essai thérapeutique en double aveugle contre placebo d'un sel de magnésium sur la symptomatologie fonctionnelle du 3ème âge. Gaz. Méd. 93, 85-88.
220. Kinnunen, O., Karpannen, H. and Salokannel, J. (1989): Safety and the effects on electrolytes of magnesium hydroxide and a bulk laxative in diuretic treated elderly patients. Magnes.-Bull. 11, 68-74.
221. Kinnunen, O. and Salokannel, J. (1989): Comparison of the effects of magnesium hydroxide and a bulk laxative on lipids carbohydrates, vitamins A and E and minerals in geriatric hospital patients in the treatment of constipations. J. International Med. Res. 17, 442-454.
222. Durlach, J., Durlach, V., Rayssiguier, Y., Bara, M. and Guiet-Bara, A. (1992): Magnesium and the cardiovascular system. II. Clinical data. In: Molecular biology of atherosclerosis, ed. M.J. Halpern, pp.513-521. London: John Libbey.
223. Durlach, J., Durlach, V., Rayssiguier, Y., Bara, M. and Guiet-Bara, A (1992): Magnesium and blood pressure. II. Clinical studies. Magnes. Res. 5, 147-153.
224. Corica, F., Allegra, A., Di Benedetto, A., Giacobbe, M.S., Romano, G., Lucinotta, D., Buemi, M. and Ceruso, D. (1994): Effects of oral magnesium supplementation on plasma lipid concentrations in patients with NIDDM. Magnes. Res. 7, 43-47.
225. Simoes-Fernandes, J. (1993): Magnesium and dyslipidemias. Clinical aspects (abs. 116). Int. J. Toxicol. Occupational Environm. Health, 2, 68-69.
226. Shechter, M. and Hod, H (1991) : Magnesium therapy in aged patients with acute myocardial infarction. Magnes.-Bull. 13, 7-9.
227. Shechter, M., Hod, H., Chouraqui, P., Kaplinskl, E. and Rabinowitz, B. (1995): Magnesium as alternative therapy in patients with acute myocardial infarction who are not candidates for thrombolytic. Therapy, 17, 75-78.